Rizatriptan Benzoate API from China
Rizatriptan benzoate is the active ingredient in Maxalt for migraine treatment, featuring a pyrazole ring in its structure. Classified under HTS 2933.19.4500 as a drug containing unfused pyrazole ring per Chapter 29 notes. Used primarily as a serotonin receptor agonist in pharmaceutical manufacturing.
Duty Rate — China → United States
28.7%
Rate breakdown
9903.88.0325%Except as provided in headings 9903.88.13, 9903.88.18, 9903.88.33, 9903.88.34, 9903.88.35, 9903.88.36, 9903.88.37, 9903.88.38, 9903.88.40, 9903.88.41, 9903.88.43, 9903.88.45, 9903.88.46, 9903.88.48, 9903.88.56, 9903.88.64, 9903.88.66, 9903.88.67, 9903.88.68, or 9903.88.69, articles the product of China, as provided for in U.S. note 20(e) to this subchapter and as provided for in the subheadings enumerated in U.S. note 20(f)
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Submit FDA IND/NDA references and stability data; ensure benzoate salt form matches US pharmacopeia specs
• Label shipments clearly as 'API - Not for Direct Human Use' to avoid Chapter 30 finished product classification
• Verify chiral purity documentation as pyrazole derivatives often require specific stereoisomer certificates